| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Notch binding | 3.16e-07 | 27 | 43 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.24e-06 | 749 | 43 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.32e-05 | 85 | 43 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.05e-05 | 188 | 43 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.66e-04 | 268 | 43 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.95e-04 | 12 | 43 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 3.48e-04 | 13 | 43 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.05e-04 | 14 | 43 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.33e-04 | 16 | 43 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | integrin binding | 5.39e-04 | 175 | 43 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.50e-04 | 891 | 43 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 7.57e-04 | 19 | 43 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 9.27e-04 | 21 | 43 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.54e-03 | 27 | 43 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 1.77e-03 | 29 | 43 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.35e-03 | 123 | 43 | 3 | GO:0030165 | |
| GeneOntologyBiologicalProcess | muscle structure development | DNER LRP2 LAMB2 LAMC1 CACNA1H CCL15 PLG DLL1 NOTCH1 ZFPM2 CNTNAP2 | 7.94e-07 | 858 | 42 | 11 | GO:0061061 |
| GeneOntologyBiologicalProcess | gliogenesis | 2.31e-06 | 435 | 42 | 8 | GO:0042063 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 3.50e-06 | 321 | 42 | 7 | GO:0010001 | |
| GeneOntologyBiologicalProcess | lateral inhibition | 1.21e-05 | 3 | 42 | 2 | GO:0046331 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cell fate commitment | 1.21e-05 | 3 | 42 | 2 | GO:0045168 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.35e-05 | 23 | 42 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | muscle organ development | 2.56e-05 | 436 | 42 | 7 | GO:0007517 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 3.20e-05 | 89 | 42 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 3.49e-05 | 91 | 42 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | mitral valve formation | 4.03e-05 | 5 | 42 | 2 | GO:0003192 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 4.03e-05 | 5 | 42 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 4.03e-05 | 5 | 42 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 4.03e-05 | 5 | 42 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 4.03e-05 | 5 | 42 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 4.44e-05 | 321 | 42 | 6 | GO:0003007 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 4.50e-05 | 34 | 42 | 3 | GO:0060977 | |
| GeneOntologyBiologicalProcess | negative regulation of myoblast differentiation | 4.50e-05 | 34 | 42 | 3 | GO:0045662 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 6.01e-05 | 339 | 42 | 6 | GO:0045927 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 6.04e-05 | 6 | 42 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 6.04e-05 | 6 | 42 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 6.04e-05 | 6 | 42 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 6.04e-05 | 6 | 42 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 6.53e-05 | 210 | 42 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | regulation of somitogenesis | 8.45e-05 | 7 | 42 | 2 | GO:0014807 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 8.89e-05 | 531 | 42 | 7 | GO:0042692 | |
| GeneOntologyBiologicalProcess | kidney development | 1.00e-04 | 372 | 42 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.06e-04 | 1190 | 42 | 10 | GO:0008284 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.14e-04 | 748 | 42 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 1.18e-04 | 238 | 42 | 5 | GO:0048639 | |
| GeneOntologyBiologicalProcess | renal system development | 1.23e-04 | 386 | 42 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | heart development | 1.24e-04 | 757 | 42 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 1.32e-04 | 128 | 42 | 4 | GO:0072009 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.32e-04 | 566 | 42 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | regulation of female gonad development | 1.44e-04 | 9 | 42 | 2 | GO:2000194 | |
| GeneOntologyBiologicalProcess | atrioventricular valve formation | 1.44e-04 | 9 | 42 | 2 | GO:0003190 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.57e-04 | 134 | 42 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.67e-04 | 136 | 42 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 1.71e-04 | 53 | 42 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 1.80e-04 | 10 | 42 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 1.80e-04 | 10 | 42 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | Notch receptor processing | 1.80e-04 | 10 | 42 | 2 | GO:0007220 | |
| GeneOntologyBiologicalProcess | loop of Henle development | 1.80e-04 | 10 | 42 | 2 | GO:0072070 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.80e-04 | 10 | 42 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.84e-04 | 802 | 42 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 2.02e-04 | 56 | 42 | 3 | GO:0060412 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 2.08e-04 | 269 | 42 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.12e-04 | 819 | 42 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 2.20e-04 | 11 | 42 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.25e-04 | 826 | 42 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 2.36e-04 | 59 | 42 | 3 | GO:0055010 | |
| GeneOntologyBiologicalProcess | regulation of inner ear receptor cell differentiation | 2.64e-04 | 12 | 42 | 2 | GO:2000980 | |
| GeneOntologyBiologicalProcess | regulation of inner ear auditory receptor cell differentiation | 2.64e-04 | 12 | 42 | 2 | GO:0045607 | |
| GeneOntologyBiologicalProcess | regulation of mechanoreceptor differentiation | 2.64e-04 | 12 | 42 | 2 | GO:0045631 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.72e-04 | 285 | 42 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.77e-04 | 286 | 42 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | axon development | 2.86e-04 | 642 | 42 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | female sex differentiation | 2.89e-04 | 157 | 42 | 4 | GO:0046660 | |
| GeneOntologyBiologicalProcess | collecting duct development | 3.11e-04 | 13 | 42 | 2 | GO:0072044 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 3.18e-04 | 161 | 42 | 4 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 3.18e-04 | 161 | 42 | 4 | GO:0003231 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 3.25e-04 | 162 | 42 | 4 | GO:0072073 | |
| GeneOntologyBiologicalProcess | myotube differentiation | 3.41e-04 | 164 | 42 | 4 | GO:0014902 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.63e-04 | 14 | 42 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 3.63e-04 | 14 | 42 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | mitral valve morphogenesis | 4.18e-04 | 15 | 42 | 2 | GO:0003183 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 4.18e-04 | 15 | 42 | 2 | GO:0048505 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell differentiation | 4.18e-04 | 15 | 42 | 2 | GO:0060837 | |
| GeneOntologyBiologicalProcess | nephron development | 4.26e-04 | 174 | 42 | 4 | GO:0072006 | |
| GeneOntologyBiologicalProcess | developmental growth | 4.35e-04 | 911 | 42 | 8 | GO:0048589 | |
| GeneOntologyBiologicalProcess | mitral valve development | 4.77e-04 | 16 | 42 | 2 | GO:0003174 | |
| GeneOntologyBiologicalProcess | negative regulation of epidermis development | 4.77e-04 | 16 | 42 | 2 | GO:0045683 | |
| GeneOntologyBiologicalProcess | negative regulation of epidermal cell differentiation | 4.77e-04 | 16 | 42 | 2 | GO:0045605 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 4.98e-04 | 76 | 42 | 3 | GO:0003229 | |
| GeneOntologyBiologicalProcess | circulatory system development | 5.04e-04 | 1442 | 42 | 10 | GO:0072359 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 5.17e-04 | 77 | 42 | 3 | GO:0055008 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 5.37e-04 | 78 | 42 | 3 | GO:0035315 | |
| GeneOntologyBiologicalProcess | heart valve formation | 5.40e-04 | 17 | 42 | 2 | GO:0003188 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 5.40e-04 | 17 | 42 | 2 | GO:0040034 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 5.57e-04 | 1194 | 42 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | neuron development | LRP2 LAMB2 LAMC1 ADAM17 BCL11A HECW1 NOTCH1 CRB1 OTOG CNTNAP2 | 5.65e-04 | 1463 | 42 | 10 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 5.78e-04 | 80 | 42 | 3 | GO:2000179 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 5.78e-04 | 80 | 42 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 6.07e-04 | 18 | 42 | 2 | GO:0060979 | |
| GeneOntologyBiologicalProcess | regulation of gonad development | 6.07e-04 | 18 | 42 | 2 | GO:1905939 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 6.44e-04 | 83 | 42 | 3 | GO:0060976 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | 6.45e-04 | 1488 | 42 | 10 | GO:0051241 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 6.67e-04 | 84 | 42 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 7.06e-04 | 199 | 42 | 4 | GO:0051147 | |
| GeneOntologyBiologicalProcess | growth | 7.11e-04 | 1235 | 42 | 9 | GO:0040007 | |
| GeneOntologyBiologicalProcess | epithelial cell fate commitment | 7.51e-04 | 20 | 42 | 2 | GO:0072148 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 7.64e-04 | 88 | 42 | 3 | GO:0003208 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 8.15e-04 | 90 | 42 | 3 | GO:0060042 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 8.29e-04 | 21 | 42 | 2 | GO:0003215 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 8.29e-04 | 21 | 42 | 2 | GO:2000047 | |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 8.29e-04 | 21 | 42 | 2 | GO:0032354 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 8.42e-04 | 91 | 42 | 3 | GO:0002067 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 8.64e-04 | 1269 | 42 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 8.69e-04 | 92 | 42 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 8.75e-04 | 558 | 42 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 8.79e-04 | 211 | 42 | 4 | GO:0060041 | |
| GeneOntologyCellularComponent | apical plasma membrane | 8.28e-06 | 487 | 45 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | extracellular matrix | 9.01e-06 | 656 | 45 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 9.23e-06 | 658 | 45 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | laminin-11 complex | 1.36e-05 | 3 | 45 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.53e-05 | 530 | 45 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | apical part of cell | 3.37e-05 | 592 | 45 | 8 | GO:0045177 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 7.41e-05 | 332 | 45 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | cell surface | 1.00e-04 | 1111 | 45 | 10 | GO:0009986 | |
| GeneOntologyCellularComponent | basement membrane | 1.37e-04 | 122 | 45 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 2.02e-04 | 10 | 45 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 6.04e-04 | 17 | 45 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | membrane raft | 1.05e-03 | 362 | 45 | 5 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.07e-03 | 364 | 45 | 5 | GO:0098857 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.67e-03 | 109 | 45 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | cell projection membrane | 2.26e-03 | 431 | 45 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.29e-03 | 33 | 45 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | plasma membrane raft | 3.90e-03 | 147 | 45 | 3 | GO:0044853 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.42e-03 | 46 | 45 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.99e-03 | 519 | 45 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 7.17e-03 | 59 | 45 | 2 | GO:0098636 | |
| HumanPheno | Hypoplasia of the iris | 5.34e-06 | 35 | 18 | 4 | HP:0007676 | |
| HumanPheno | Motor stereotypy | 2.65e-05 | 280 | 18 | 7 | HP:0000733 | |
| MousePheno | hemorrhage | LAMC1 ADAM17 TM2D3 FBN1 ZBTB20 PLG DLL1 TIMP1 NOTCH1 VCAN ZFPM2 | 1.90e-07 | 664 | 33 | 11 | MP:0001914 |
| MousePheno | abnormal blood circulation | LAMC1 ADAM17 TM2D3 FBN1 ZBTB20 PLG DLL1 TIMP1 NOTCH1 VCAN ZFPM2 | 2.09e-06 | 845 | 33 | 11 | MP:0002128 |
| MousePheno | internal hemorrhage | 2.43e-06 | 387 | 33 | 8 | MP:0001634 | |
| MousePheno | abnormal heart right ventricle morphology | 2.99e-05 | 156 | 33 | 5 | MP:0003920 | |
| MousePheno | abnormal blood vessel physiology | 3.04e-05 | 394 | 33 | 7 | MP:0000249 | |
| MousePheno | abnormal vasculature physiology | 3.56e-05 | 404 | 33 | 7 | MP:0031170 | |
| MousePheno | thick semilunar valve | 4.66e-05 | 30 | 33 | 3 | MP:0031584 | |
| MousePheno | aneurysm | 7.45e-05 | 35 | 33 | 3 | MP:0003279 | |
| MousePheno | abnormal blood vessel morphology | LRP2 LAMC1 CACNA1H ADAM17 FBN1 PLG DLL1 TIMP1 NOTCH1 VCAN ZFPM2 CRB1 | 7.63e-05 | 1472 | 33 | 12 | MP:0001614 |
| MousePheno | enlarged pulmonary valve | 8.06e-05 | 6 | 33 | 2 | MP:0010600 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | LRP2 LAMB2 LAMC1 ADAM17 BCL11A FBN1 DLL1 NSD2 VCAN ZFPM2 INSR | 9.77e-05 | 1269 | 33 | 11 | MP:0011111 |
| MousePheno | pathological neovascularization | 1.16e-04 | 108 | 33 | 4 | MP:0003711 | |
| MousePheno | abnormal heart left ventricle morphology | 1.97e-04 | 369 | 33 | 6 | MP:0003921 | |
| MousePheno | dilated heart atrium | 2.05e-04 | 49 | 33 | 3 | MP:0003140 | |
| MousePheno | enlarged semilunar valve | 2.93e-04 | 11 | 33 | 2 | MP:0031580 | |
| MousePheno | abnormal lung development | 3.32e-04 | 142 | 33 | 4 | MP:0001176 | |
| MousePheno | ventricular septal defect | 3.38e-04 | 261 | 33 | 5 | MP:0010402 | |
| MousePheno | eye hemorrhage | 3.74e-04 | 60 | 33 | 3 | MP:0006203 | |
| MousePheno | abnormal CNS glial cell morphology | 4.08e-04 | 272 | 33 | 5 | MP:0000952 | |
| MousePheno | aortic aneurysm | 4.83e-04 | 14 | 33 | 2 | MP:0006278 | |
| MousePheno | decreased basal metabolism | 4.83e-04 | 14 | 33 | 2 | MP:0020234 | |
| MousePheno | abnormal artery morphology | 5.05e-04 | 440 | 33 | 6 | MP:0002191 | |
| MousePheno | abnormal respiratory system development | 5.22e-04 | 160 | 33 | 4 | MP:0003115 | |
| MousePheno | abnormal mitral valve cusp morphology | 5.57e-04 | 15 | 33 | 2 | MP:0010614 | |
| MousePheno | abnormal heart valve morphology | 5.60e-04 | 163 | 33 | 4 | MP:0000285 | |
| MousePheno | abnormal atrioventricular valve morphology | 5.65e-04 | 69 | 33 | 3 | MP:0002745 | |
| MousePheno | abnormal aortic valve morphology | 6.40e-04 | 72 | 33 | 3 | MP:0002747 | |
| MousePheno | abnormal heart left ventricle outflow tract morphology | 6.40e-04 | 72 | 33 | 3 | MP:0010429 | |
| MousePheno | thick pulmonary valve | 7.19e-04 | 17 | 33 | 2 | MP:0010601 | |
| MousePheno | abnormal heart atrium and ventricle connection | 7.21e-04 | 75 | 33 | 3 | MP:0010435 | |
| MousePheno | abnormal muscle morphology | 7.96e-04 | 1106 | 33 | 9 | MP:0002108 | |
| MousePheno | increased circulating estradiol level | 8.08e-04 | 18 | 33 | 2 | MP:0005182 | |
| MousePheno | abnormal cardiac epithelial to mesenchymal transition | 8.08e-04 | 18 | 33 | 2 | MP:0008825 | |
| MousePheno | abnormal respiratory conducting tube morphology | 8.39e-04 | 79 | 33 | 3 | MP:0004391 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 8.80e-04 | 489 | 33 | 6 | MP:0010630 | |
| MousePheno | increased circulating estrogen level | 9.01e-04 | 19 | 33 | 2 | MP:0003370 | |
| MousePheno | thick aortic valve cusps | 9.01e-04 | 19 | 33 | 2 | MP:0010593 | |
| MousePheno | abnormal trachea morphology | 9.02e-04 | 81 | 33 | 3 | MP:0002282 | |
| MousePheno | abnormal Muller cell morphology | 1.00e-03 | 20 | 33 | 2 | MP:0005547 | |
| MousePheno | thick lung-associated mesenchyme | 1.00e-03 | 20 | 33 | 2 | MP:0011143 | |
| MousePheno | abnormal interventricular septum morphology | 1.15e-03 | 342 | 33 | 5 | MP:0000281 | |
| Domain | EGF-like_dom | DNER LRP2 UMOD LAMB2 LAMC1 FBN1 STAB2 DLL1 NOTCH1 VCAN CRB1 OTOG CNTNAP2 | 3.89e-15 | 249 | 41 | 13 | IPR000742 |
| Domain | EGF-like_CS | DNER LRP2 UMOD LAMB2 LAMC1 ADAM17 FBN1 STAB2 DLL1 NOTCH1 VCAN CRB1 CNTNAP2 | 7.15e-15 | 261 | 41 | 13 | IPR013032 |
| Domain | Growth_fac_rcpt_ | 2.46e-14 | 156 | 41 | 11 | IPR009030 | |
| Domain | EGF | DNER LRP2 UMOD LAMB2 LAMC1 FBN1 STAB2 DLL1 NOTCH1 VCAN CRB1 CNTNAP2 | 6.80e-14 | 235 | 41 | 12 | SM00181 |
| Domain | EGF_1 | DNER LRP2 UMOD LAMB2 LAMC1 FBN1 STAB2 DLL1 NOTCH1 VCAN CRB1 CNTNAP2 | 1.80e-13 | 255 | 41 | 12 | PS00022 |
| Domain | EGF_2 | DNER LRP2 UMOD LAMB2 LAMC1 FBN1 STAB2 DLL1 NOTCH1 VCAN CRB1 CNTNAP2 | 2.84e-13 | 265 | 41 | 12 | PS01186 |
| Domain | EGF_3 | DNER LRP2 UMOD FBN1 STAB2 DLL1 NOTCH1 VCAN CRB1 OTOG CNTNAP2 | 2.24e-12 | 235 | 41 | 11 | PS50026 |
| Domain | EGF_CA | 4.72e-12 | 122 | 41 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.47e-12 | 124 | 41 | 9 | IPR001881 | |
| Domain | EGF | 6.33e-12 | 126 | 41 | 9 | PF00008 | |
| Domain | EGF_Ca-bd_CS | 3.27e-11 | 97 | 41 | 8 | IPR018097 | |
| Domain | EGF_CA | 3.87e-11 | 99 | 41 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.20e-11 | 100 | 41 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.73e-11 | 106 | 41 | 8 | IPR000152 | |
| Domain | hEGF | 3.94e-07 | 28 | 41 | 4 | PF12661 | |
| Domain | TIL_dom | 3.51e-06 | 14 | 41 | 3 | IPR002919 | |
| Domain | EGF_extracell | 8.92e-06 | 60 | 41 | 4 | IPR013111 | |
| Domain | EGF_2 | 8.92e-06 | 60 | 41 | 4 | PF07974 | |
| Domain | EGF_CA | 3.73e-05 | 86 | 41 | 4 | PF07645 | |
| Domain | EGF_LAM_2 | 3.83e-05 | 30 | 41 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 3.83e-05 | 30 | 41 | 3 | PS01248 | |
| Domain | EGF_Lam | 6.12e-05 | 35 | 41 | 3 | SM00180 | |
| Domain | Laminin_EGF | 7.85e-05 | 38 | 41 | 3 | IPR002049 | |
| Domain | - | 9.66e-05 | 679 | 41 | 8 | 3.30.160.60 | |
| Domain | Notch_dom | 9.81e-05 | 7 | 41 | 2 | IPR000800 | |
| Domain | Notch | 9.81e-05 | 7 | 41 | 2 | PF00066 | |
| Domain | NL | 9.81e-05 | 7 | 41 | 2 | SM00004 | |
| Domain | VWF_dom | 1.06e-04 | 42 | 41 | 3 | IPR001007 | |
| Domain | zf-C2H2 | 1.11e-04 | 693 | 41 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.12e-04 | 694 | 41 | 8 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.40e-04 | 775 | 41 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.44e-04 | 777 | 41 | 8 | PS00028 | |
| Domain | - | 2.55e-04 | 11 | 41 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 2.55e-04 | 11 | 41 | 2 | IPR023413 | |
| Domain | Znf_C2H2-like | 2.87e-04 | 796 | 41 | 8 | IPR015880 | |
| Domain | EGF_3 | 3.06e-04 | 12 | 41 | 2 | PF12947 | |
| Domain | TIL | 3.06e-04 | 12 | 41 | 2 | PF01826 | |
| Domain | EGF_dom | 3.06e-04 | 12 | 41 | 2 | IPR024731 | |
| Domain | C8 | 3.06e-04 | 12 | 41 | 2 | PF08742 | |
| Domain | Znf_C2H2 | 3.10e-04 | 805 | 41 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 3.18e-04 | 808 | 41 | 8 | SM00355 | |
| Domain | LINK | 3.61e-04 | 13 | 41 | 2 | SM00445 | |
| Domain | Unchr_dom_Cys-rich | 3.61e-04 | 13 | 41 | 2 | IPR014853 | |
| Domain | Link_dom | 3.61e-04 | 13 | 41 | 2 | IPR000538 | |
| Domain | C8 | 3.61e-04 | 13 | 41 | 2 | SM00832 | |
| Domain | Xlink | 3.61e-04 | 13 | 41 | 2 | PF00193 | |
| Domain | LINK_1 | 3.61e-04 | 13 | 41 | 2 | PS01241 | |
| Domain | LINK_2 | 3.61e-04 | 13 | 41 | 2 | PS50963 | |
| Domain | VWD | 5.53e-04 | 16 | 41 | 2 | SM00216 | |
| Domain | VWF_type-D | 5.53e-04 | 16 | 41 | 2 | IPR001846 | |
| Domain | Laminin_N | 5.53e-04 | 16 | 41 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 5.53e-04 | 16 | 41 | 2 | PS51117 | |
| Domain | VWFD | 5.53e-04 | 16 | 41 | 2 | PS51233 | |
| Domain | Laminin_N | 5.53e-04 | 16 | 41 | 2 | PF00055 | |
| Domain | VWD | 5.53e-04 | 16 | 41 | 2 | PF00094 | |
| Domain | LamNT | 5.53e-04 | 16 | 41 | 2 | SM00136 | |
| Domain | VWC_out | 7.85e-04 | 19 | 41 | 2 | SM00215 | |
| Domain | CT | 1.06e-03 | 22 | 41 | 2 | SM00041 | |
| Domain | Galactose-bd-like | 1.15e-03 | 94 | 41 | 3 | IPR008979 | |
| Domain | - | 1.18e-03 | 95 | 41 | 3 | 2.60.120.200 | |
| Domain | Cys_knot_C | 1.37e-03 | 25 | 41 | 2 | IPR006207 | |
| Domain | CTCK_2 | 1.37e-03 | 25 | 41 | 2 | PS01225 | |
| Domain | cEGF | 1.48e-03 | 26 | 41 | 2 | IPR026823 | |
| Domain | cEGF | 1.48e-03 | 26 | 41 | 2 | PF12662 | |
| Domain | Laminin_EGF | 2.67e-03 | 35 | 41 | 2 | PF00053 | |
| Domain | VWFC_1 | 2.83e-03 | 36 | 41 | 2 | PS01208 | |
| Domain | VWC | 3.14e-03 | 38 | 41 | 2 | SM00214 | |
| Domain | VWFC_2 | 3.14e-03 | 38 | 41 | 2 | PS50184 | |
| Domain | LAM_G_DOMAIN | 3.14e-03 | 38 | 41 | 2 | PS50025 | |
| Domain | Keratin_B2_2 | 3.31e-03 | 39 | 41 | 2 | PF13885 | |
| Domain | Laminin_G_2 | 3.48e-03 | 40 | 41 | 2 | PF02210 | |
| Domain | LamG | 4.20e-03 | 44 | 41 | 2 | SM00282 | |
| Domain | Sushi | 5.82e-03 | 52 | 41 | 2 | PF00084 | |
| Domain | CCP | 6.26e-03 | 54 | 41 | 2 | SM00032 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.21e-08 | 124 | 33 | 7 | M27285 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 2.33e-07 | 6 | 33 | 3 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 2.33e-07 | 6 | 33 | 3 | M22074 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 4.06e-07 | 7 | 33 | 3 | M27199 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 7.49e-07 | 31 | 33 | 4 | M592 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 4.18e-06 | 14 | 33 | 3 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 4.18e-06 | 14 | 33 | 3 | M16173 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.90e-06 | 300 | 33 | 7 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 5.22e-06 | 15 | 33 | 3 | M27202 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.71e-05 | 140 | 33 | 5 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.55e-05 | 74 | 33 | 4 | M616 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.29e-05 | 27 | 33 | 3 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.47e-04 | 8 | 33 | 2 | M47850 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.55e-04 | 45 | 33 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.66e-04 | 46 | 33 | 3 | MM15971 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.69e-04 | 120 | 33 | 4 | MM14982 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.77e-04 | 47 | 33 | 3 | M7946 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 1.89e-04 | 9 | 33 | 2 | M39869 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 2.36e-04 | 10 | 33 | 2 | MM15839 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 2.67e-04 | 54 | 33 | 3 | M39337 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 2.88e-04 | 11 | 33 | 2 | M39647 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M158 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.88e-04 | 11 | 33 | 2 | M47865 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 3.30e-04 | 58 | 33 | 3 | M29616 | |
| Pathway | BIOCARTA_HES_PATHWAY | 3.46e-04 | 12 | 33 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 3.46e-04 | 12 | 33 | 2 | M22042 | |
| Pathway | PID_NOTCH_PATHWAY | 3.47e-04 | 59 | 33 | 3 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.83e-04 | 61 | 33 | 3 | M39540 | |
| Pathway | WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT | 4.02e-04 | 62 | 33 | 3 | M45532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47423 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.84e-04 | 66 | 33 | 3 | M18 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 6.25e-04 | 16 | 33 | 2 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 7.07e-04 | 17 | 33 | 2 | M39389 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.31e-04 | 76 | 33 | 3 | M27219 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 9.13e-04 | 82 | 33 | 3 | MM15922 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.44e-03 | 96 | 33 | 3 | M39581 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.22e-03 | 30 | 33 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.22e-03 | 30 | 33 | 2 | M27216 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.22e-03 | 30 | 33 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.22e-03 | 30 | 33 | 2 | MM15812 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.35e-03 | 114 | 33 | 3 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.49e-03 | 246 | 33 | 4 | M10189 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.68e-03 | 33 | 33 | 2 | M39503 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 2.68e-03 | 33 | 33 | 2 | M26976 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.95e-03 | 258 | 33 | 4 | MM14572 | |
| Pathway | KEGG_PRION_DISEASES | 3.01e-03 | 35 | 33 | 2 | M13036 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 3.54e-03 | 38 | 33 | 2 | MM14611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.73e-03 | 39 | 33 | 2 | MM14604 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.12e-03 | 41 | 33 | 2 | M27778 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 4.52e-03 | 43 | 33 | 2 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.52e-03 | 43 | 33 | 2 | M53 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 5.16e-03 | 46 | 33 | 2 | M239 | |
| Pathway | PID_PS1_PATHWAY | 5.16e-03 | 46 | 33 | 2 | M70 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.10e-08 | 248 | 45 | 7 | 24006456 | |
| Pubmed | 3.52e-08 | 71 | 45 | 5 | 33541421 | ||
| Pubmed | 4.64e-08 | 153 | 45 | 6 | 25037231 | ||
| Pubmed | 7.81e-08 | 167 | 45 | 6 | 22159717 | ||
| Pubmed | 1.69e-07 | 9 | 45 | 3 | 15574878 | ||
| Pubmed | 1.69e-07 | 9 | 45 | 3 | 11675412 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.82e-07 | 135 | 45 | 5 | 28675934 | |
| Pubmed | 9.11e-07 | 15 | 45 | 3 | 25725069 | ||
| Pubmed | Interaction of human pregnancy-associated plasma protein-A with serine proteinases. | 1.64e-06 | 2 | 45 | 2 | 7586586 | |
| Pubmed | Cis-interactions between Notch and Delta generate mutually exclusive signalling states. | 1.64e-06 | 2 | 45 | 2 | 20418862 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 21549686 | ||
| Pubmed | Zfp64 participates in Notch signaling and regulates differentiation in mesenchymal cells. | 1.64e-06 | 2 | 45 | 2 | 18430783 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 11726670 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26014475 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 28486700 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20551051 | ||
| Pubmed | Notch1 endocytosis is induced by ligand and is required for signal transduction. | 1.64e-06 | 2 | 45 | 2 | 26522918 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23963449 | ||
| Pubmed | Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. | 1.64e-06 | 2 | 45 | 2 | 9620803 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 10882063 | ||
| Pubmed | Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line. | 1.64e-06 | 2 | 45 | 2 | 19724883 | |
| Pubmed | Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. | 1.64e-06 | 2 | 45 | 2 | 22249198 | |
| Pubmed | A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. | 1.64e-06 | 2 | 45 | 2 | 2922051 | |
| Pubmed | NOTCH, a new signaling pathway implicated in holoprosencephaly. | 1.64e-06 | 2 | 45 | 2 | 21196490 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 33905845 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 25744398 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17878313 | ||
| Pubmed | Spatiotemporal oscillations of Notch1, Dll1 and NICD are coordinated across the mouse PSM. | 1.64e-06 | 2 | 45 | 2 | 25468943 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 21643850 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26744411 | ||
| Pubmed | Generation of Distal Renal Segments Involves a Unique Population of Aqp2 + Progenitor Cells. | 1.93e-06 | 19 | 45 | 3 | 34667084 | |
| Pubmed | 2.27e-06 | 20 | 45 | 3 | 21750040 | ||
| Pubmed | 2.65e-06 | 21 | 45 | 3 | 16079250 | ||
| Pubmed | FGF signaling expands embryonic cortical surface area by regulating Notch-dependent neurogenesis. | 3.06e-06 | 22 | 45 | 3 | 22031906 | |
| Pubmed | 3.06e-06 | 22 | 45 | 3 | 27117402 | ||
| Pubmed | 3.52e-06 | 23 | 45 | 3 | 19549527 | ||
| Pubmed | 3.52e-06 | 23 | 45 | 3 | 29567669 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 18320325 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 4.91e-06 | 3 | 45 | 2 | 20812035 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21985982 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12050162 | ||
| Pubmed | Both Notch1 and its ligands in B cells promote antibody production. | 4.91e-06 | 3 | 45 | 2 | 28863329 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 22080880 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21602795 | ||
| Pubmed | Verification of microRNA expression in human endometrial adenocarcinoma. | 4.91e-06 | 3 | 45 | 2 | 27039384 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23122949 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 15781650 | ||
| Pubmed | Laminin-121--recombinant expression and interactions with integrins. | 4.91e-06 | 3 | 45 | 2 | 20566382 | |
| Pubmed | Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. | 4.91e-06 | 3 | 45 | 2 | 19704010 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 33673337 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23072809 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 37260223 | ||
| Pubmed | Notch signaling confers antigen-presenting cell functions on mast cells. | 4.91e-06 | 3 | 45 | 2 | 19130928 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 18676613 | ||
| Pubmed | Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection. | 4.91e-06 | 3 | 45 | 2 | 29515038 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 7698745 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 19027012 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 10481268 | ||
| Pubmed | Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix. | 4.91e-06 | 3 | 45 | 2 | 6209134 | |
| Pubmed | Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1. | 4.91e-06 | 3 | 45 | 2 | 23839946 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 34519870 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 30110645 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 15976178 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 5.15e-06 | 26 | 45 | 3 | 34189436 | |
| Pubmed | 6.02e-06 | 91 | 45 | 4 | 21194568 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 7.22e-06 | 560 | 45 | 7 | 21653829 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 7.76e-06 | 97 | 45 | 4 | 27559042 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 9.11e-06 | 101 | 45 | 4 | 20551380 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 9.11e-06 | 101 | 45 | 4 | 23382219 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 18824585 | ||
| Pubmed | Notch signalling pathway mediates hair cell development in mammalian cochlea. | 9.81e-06 | 4 | 45 | 2 | 10080181 | |
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 9.81e-06 | 4 | 45 | 2 | 22390640 | |
| Pubmed | Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. | 9.81e-06 | 4 | 45 | 2 | 9244302 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 16317090 | ||
| Pubmed | Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. | 9.81e-06 | 4 | 45 | 2 | 19383720 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 9858728 | ||
| Pubmed | Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. | 9.81e-06 | 4 | 45 | 2 | 11044625 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 27354212 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 24951930 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 16294222 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 9315665 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 9.81e-06 | 4 | 45 | 2 | 32820046 | |
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 9.81e-06 | 4 | 45 | 2 | 23300864 | |
| Pubmed | DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. | 9.81e-06 | 4 | 45 | 2 | 19144989 | |
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 9.81e-06 | 4 | 45 | 2 | 35008625 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 18299190 | ||
| Pubmed | Notch controls the survival of memory CD4+ T cells by regulating glucose uptake. | 9.81e-06 | 4 | 45 | 2 | 25501905 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 23162128 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 23657465 | ||
| Pubmed | Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. | 9.81e-06 | 4 | 45 | 2 | 16146715 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 8034675 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 7670489 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 19110448 | ||
| Pubmed | Immunohistochemical expression of Notch signaling in the lining epithelium of periapical cysts. | 1.63e-05 | 5 | 45 | 2 | 21238798 | |
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 12354787 | ||
| Pubmed | Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. | 1.63e-05 | 5 | 45 | 2 | 21273553 | |
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 11713346 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 22445366 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 12175503 | ||
| Pubmed | Nrf2 Transcriptional Activity Governs Intestine Development. | 1.63e-05 | 5 | 45 | 2 | 35682851 | |
| Interaction | FBXO2 interactions | 2.11e-07 | 411 | 44 | 9 | int:FBXO2 | |
| Interaction | IGFL3 interactions | 6.05e-07 | 75 | 44 | 5 | int:IGFL3 | |
| Interaction | NCR3 interactions | 6.21e-06 | 120 | 44 | 5 | int:NCR3 | |
| Interaction | TAFA4 interactions | 6.21e-06 | 55 | 44 | 4 | int:TAFA4 | |
| Interaction | ITGB4 interactions | 7.58e-06 | 125 | 44 | 5 | int:ITGB4 | |
| Interaction | ZDHHC15 interactions | 7.58e-06 | 125 | 44 | 5 | int:ZDHHC15 | |
| Interaction | TAPBPL interactions | 9.18e-06 | 19 | 44 | 3 | int:TAPBPL | |
| Interaction | HOXA1 interactions | 1.11e-05 | 356 | 44 | 7 | int:HOXA1 | |
| Interaction | ZNF408 interactions | 1.56e-05 | 145 | 44 | 5 | int:ZNF408 | |
| Interaction | NTN5 interactions | 1.90e-05 | 24 | 44 | 3 | int:NTN5 | |
| Interaction | SLC23A1 interactions | 2.44e-05 | 26 | 44 | 3 | int:SLC23A1 | |
| Interaction | ZNF580 interactions | 4.61e-05 | 32 | 44 | 3 | int:ZNF580 | |
| Interaction | ZNF697 interactions | 5.06e-05 | 33 | 44 | 3 | int:ZNF697 | |
| Interaction | SDF2L1 interactions | 6.72e-05 | 322 | 44 | 6 | int:SDF2L1 | |
| Interaction | LY86 interactions | 1.07e-04 | 217 | 44 | 5 | int:LY86 | |
| Interaction | BRME1 interactions | 1.21e-04 | 44 | 44 | 3 | int:BRME1 | |
| Interaction | DNER interactions | 1.29e-04 | 8 | 44 | 2 | int:DNER | |
| Interaction | AEN interactions | 1.47e-04 | 47 | 44 | 3 | int:AEN | |
| Interaction | WNT3A interactions | 1.67e-04 | 49 | 44 | 3 | int:WNT3A | |
| Interaction | GGH interactions | 1.81e-04 | 243 | 44 | 5 | int:GGH | |
| Interaction | CCDC26 interactions | 2.07e-04 | 10 | 44 | 2 | int:CCDC26 | |
| Interaction | ZNF587 interactions | 2.12e-04 | 135 | 44 | 4 | int:ZNF587 | |
| Interaction | HBZ interactions | 2.23e-04 | 54 | 44 | 3 | int:HBZ | |
| Interaction | MXI1 interactions | 2.35e-04 | 55 | 44 | 3 | int:MXI1 | |
| Interaction | MYPOP interactions | 2.35e-04 | 55 | 44 | 3 | int:MYPOP | |
| Interaction | POM121L8P interactions | 2.53e-04 | 11 | 44 | 2 | int:POM121L8P | |
| Interaction | ZFP41 interactions | 2.62e-04 | 57 | 44 | 3 | int:ZFP41 | |
| Interaction | SLURP1 interactions | 2.72e-04 | 144 | 44 | 4 | int:SLURP1 | |
| Interaction | INSL5 interactions | 2.76e-04 | 58 | 44 | 3 | int:INSL5 | |
| Interaction | WDR25 interactions | 2.76e-04 | 58 | 44 | 3 | int:WDR25 | |
| Interaction | ZNF124 interactions | 2.90e-04 | 59 | 44 | 3 | int:ZNF124 | |
| Interaction | CTSZ interactions | 2.90e-04 | 59 | 44 | 3 | int:CTSZ | |
| Interaction | ITGB5 interactions | 2.94e-04 | 147 | 44 | 4 | int:ITGB5 | |
| Interaction | GLIDR interactions | 3.03e-04 | 12 | 44 | 2 | int:GLIDR | |
| Interaction | LCE3E interactions | 3.05e-04 | 60 | 44 | 3 | int:LCE3E | |
| Interaction | SPATA24 interactions | 3.05e-04 | 60 | 44 | 3 | int:SPATA24 | |
| Interaction | FAM27E3 interactions | 3.58e-04 | 13 | 44 | 2 | int:FAM27E3 | |
| Interaction | PRG2 interactions | 3.78e-04 | 285 | 44 | 5 | int:PRG2 | |
| Interaction | ZBTB24 interactions | 3.96e-04 | 159 | 44 | 4 | int:ZBTB24 | |
| Interaction | FBLN2 interactions | 4.04e-04 | 66 | 44 | 3 | int:FBLN2 | |
| Interaction | PHLDA1 interactions | 4.04e-04 | 66 | 44 | 3 | int:PHLDA1 | |
| Interaction | DOCK2 interactions | 4.04e-04 | 66 | 44 | 3 | int:DOCK2 | |
| Interaction | ZNF26 interactions | 4.17e-04 | 14 | 44 | 2 | int:ZNF26 | |
| Interaction | ZNF844 interactions | 4.17e-04 | 14 | 44 | 2 | int:ZNF844 | |
| Interaction | RTN4RL1 interactions | 4.17e-04 | 14 | 44 | 2 | int:RTN4RL1 | |
| Interaction | LCE3C interactions | 4.22e-04 | 67 | 44 | 3 | int:LCE3C | |
| Interaction | LCE1E interactions | 4.41e-04 | 68 | 44 | 3 | int:LCE1E | |
| Interaction | KRT83 interactions | 4.41e-04 | 68 | 44 | 3 | int:KRT83 | |
| Interaction | CREB5 interactions | 4.45e-04 | 164 | 44 | 4 | int:CREB5 | |
| Interaction | MBD3L1 interactions | 4.80e-04 | 70 | 44 | 3 | int:MBD3L1 | |
| Interaction | ZNF266 interactions | 4.80e-04 | 15 | 44 | 2 | int:ZNF266 | |
| Interaction | ZNF625 interactions | 4.80e-04 | 15 | 44 | 2 | int:ZNF625 | |
| Interaction | CHIC2 interactions | 5.43e-04 | 73 | 44 | 3 | int:CHIC2 | |
| Interaction | CCER1 interactions | 5.48e-04 | 16 | 44 | 2 | int:CCER1 | |
| Interaction | MAPKBP1 interactions | 5.65e-04 | 74 | 44 | 3 | int:MAPKBP1 | |
| Interaction | CST11 interactions | 5.88e-04 | 75 | 44 | 3 | int:CST11 | |
| Interaction | ZNF337 interactions | 6.21e-04 | 17 | 44 | 2 | int:ZNF337 | |
| Interaction | CATIP interactions | 6.21e-04 | 17 | 44 | 2 | int:CATIP | |
| Interaction | ZNF707 interactions | 6.84e-04 | 79 | 44 | 3 | int:ZNF707 | |
| Interaction | KRTAP4-4 interactions | 7.36e-04 | 81 | 44 | 3 | int:KRTAP4-4 | |
| Interaction | ZNF138 interactions | 7.78e-04 | 19 | 44 | 2 | int:ZNF138 | |
| Interaction | LCE1B interactions | 8.46e-04 | 85 | 44 | 3 | int:LCE1B | |
| Interaction | NPBWR2 interactions | 8.63e-04 | 20 | 44 | 2 | int:NPBWR2 | |
| Interaction | DMRT3 interactions | 9.06e-04 | 87 | 44 | 3 | int:DMRT3 | |
| Interaction | LCE2C interactions | 9.36e-04 | 88 | 44 | 3 | int:LCE2C | |
| Interaction | ZNF786 interactions | 9.53e-04 | 21 | 44 | 2 | int:ZNF786 | |
| Interaction | GARIN6 interactions | 9.53e-04 | 21 | 44 | 2 | int:GARIN6 | |
| Interaction | ZNF543 interactions | 9.53e-04 | 21 | 44 | 2 | int:ZNF543 | |
| Interaction | ANKRD36BP1 interactions | 9.53e-04 | 21 | 44 | 2 | int:ANKRD36BP1 | |
| Interaction | CXCL16 interactions | 9.67e-04 | 89 | 44 | 3 | int:CXCL16 | |
| Interaction | PAPPA interactions | 1.05e-03 | 22 | 44 | 2 | int:PAPPA | |
| Interaction | LCE1F interactions | 1.06e-03 | 92 | 44 | 3 | int:LCE1F | |
| Interaction | RLN1 interactions | 1.10e-03 | 93 | 44 | 3 | int:RLN1 | |
| Interaction | CHRD interactions | 1.13e-03 | 94 | 44 | 3 | int:CHRD | |
| Interaction | KRTAP5-6 interactions | 1.13e-03 | 94 | 44 | 3 | int:KRTAP5-6 | |
| Interaction | IL10 interactions | 1.14e-03 | 23 | 44 | 2 | int:IL10 | |
| Interaction | MOBP interactions | 1.14e-03 | 23 | 44 | 2 | int:MOBP | |
| Interaction | CHRNG interactions | 1.14e-03 | 23 | 44 | 2 | int:CHRNG | |
| Interaction | NTN4 interactions | 1.14e-03 | 23 | 44 | 2 | int:NTN4 | |
| Interaction | ADAMTS1 interactions | 1.17e-03 | 95 | 44 | 3 | int:ADAMTS1 | |
| Interaction | TSHR interactions | 1.20e-03 | 96 | 44 | 3 | int:TSHR | |
| Interaction | SHFL interactions | 1.24e-03 | 97 | 44 | 3 | int:SHFL | |
| Interaction | KLHL38 interactions | 1.32e-03 | 99 | 44 | 3 | int:KLHL38 | |
| Interaction | GNE interactions | 1.52e-03 | 104 | 44 | 3 | int:GNE | |
| Interaction | ZNF319 interactions | 1.58e-03 | 27 | 44 | 2 | int:ZNF319 | |
| Interaction | KRTAP10-10 interactions | 1.58e-03 | 27 | 44 | 2 | int:KRTAP10-10 | |
| Interaction | ZNF439 interactions | 1.58e-03 | 27 | 44 | 2 | int:ZNF439 | |
| Interaction | MFNG interactions | 1.58e-03 | 27 | 44 | 2 | int:MFNG | |
| Interaction | ZNF575 interactions | 1.58e-03 | 27 | 44 | 2 | int:ZNF575 | |
| Interaction | TNFAIP6 interactions | 1.58e-03 | 27 | 44 | 2 | int:TNFAIP6 | |
| Interaction | FAM74A4 interactions | 1.58e-03 | 27 | 44 | 2 | int:FAM74A4 | |
| Interaction | FEZF1 interactions | 1.70e-03 | 28 | 44 | 2 | int:FEZF1 | |
| Interaction | LIMS2 interactions | 1.70e-03 | 28 | 44 | 2 | int:LIMS2 | |
| GeneFamily | Neuroblastoma breakpoint family | 9.57e-06 | 23 | 33 | 3 | 662 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.42e-05 | 718 | 33 | 8 | 28 | |
| GeneFamily | Laminin subunits | 2.11e-04 | 12 | 33 | 2 | 626 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.84e-03 | 57 | 33 | 2 | 1179 | |
| Coexpression | NABA_MATRISOME | LAMB2 LAMC1 PAPPA ADAM17 CCL15 FBN1 PLG TIMP1 MUC2 ECM2 EGFEM1P VCAN OTOG | 8.67e-09 | 1008 | 45 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | LAMB2 LAMC1 PAPPA ADAM17 CCL15 FBN1 PLG TIMP1 MUC2 ECM2 VCAN OTOG | 1.06e-07 | 1026 | 45 | 12 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 3.70e-07 | 270 | 45 | 7 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.90e-07 | 191 | 45 | 6 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 7.30e-06 | 275 | 45 | 6 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.13e-05 | 196 | 45 | 5 | M3008 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.35e-05 | 200 | 45 | 5 | M5930 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.98e-05 | 35 | 45 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.24e-05 | 36 | 45 | 3 | MM1212 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 4.30e-05 | 6 | 45 | 2 | M48000 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 5.18e-05 | 42 | 45 | 3 | M5895 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 9.23e-05 | 1106 | 45 | 9 | M39071 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 1.22e-04 | 283 | 45 | 5 | M39117 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 1.34e-04 | 289 | 45 | 5 | M41750 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ENS_NEURONS | 1.84e-04 | 165 | 45 | 4 | M40270 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.10e-05 | 118 | 40 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 8.90e-05 | 783 | 40 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 9.35e-05 | 398 | 40 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.56e-04 | 437 | 40 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.72e-04 | 445 | 40 | 6 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.75e-04 | 149 | 40 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.76e-04 | 447 | 40 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-09 | 199 | 45 | 7 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-08 | 187 | 45 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-08 | 187 | 45 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-08 | 187 | 45 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-08 | 192 | 45 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-08 | 193 | 45 | 6 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-08 | 193 | 45 | 6 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-08 | 195 | 45 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-08 | 195 | 45 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-08 | 195 | 45 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-08 | 197 | 45 | 6 | 6b6440f1baad5680cf9e13ca3ab72a2c65523d59 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.61e-08 | 197 | 45 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.31e-07 | 176 | 45 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-06 | 182 | 45 | 5 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-06 | 182 | 45 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 182 | 45 | 5 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-06 | 183 | 45 | 5 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-06 | 184 | 45 | 5 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 185 | 45 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 186 | 45 | 5 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 186 | 45 | 5 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.26e-06 | 187 | 45 | 5 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 189 | 45 | 5 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 189 | 45 | 5 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-06 | 190 | 45 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 191 | 45 | 5 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.39e-06 | 191 | 45 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 192 | 45 | 5 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 192 | 45 | 5 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 192 | 45 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 192 | 45 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 193 | 45 | 5 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-06 | 193 | 45 | 5 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-06 | 193 | 45 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 193 | 45 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.50e-06 | 194 | 45 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.50e-06 | 194 | 45 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.50e-06 | 194 | 45 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 195 | 45 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.54e-06 | 195 | 45 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 195 | 45 | 5 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 196 | 45 | 5 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 196 | 45 | 5 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.58e-06 | 196 | 45 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-06 | 198 | 45 | 5 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 198 | 45 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-06 | 198 | 45 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-06 | 199 | 45 | 5 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.70e-06 | 199 | 45 | 5 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.70e-06 | 199 | 45 | 5 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-06 | 199 | 45 | 5 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-06 | 199 | 45 | 5 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-06 | 200 | 45 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 200 | 45 | 5 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 200 | 45 | 5 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-06 | 200 | 45 | 5 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 45 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 200 | 45 | 5 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 45 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 45 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-06 | 200 | 45 | 5 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-06 | 200 | 45 | 5 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.51e-05 | 148 | 45 | 4 | c95a732163050cfb5d604c2a4c9eb1afa9f19a95 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.76e-05 | 154 | 45 | 4 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.76e-05 | 154 | 45 | 4 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.76e-05 | 154 | 45 | 4 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.76e-05 | 154 | 45 | 4 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 2.26e-05 | 164 | 45 | 4 | 7766900740f67dbbe3c4d90fbfdcc1665cee6515 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 169 | 45 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 171 | 45 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 171 | 45 | 4 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 171 | 45 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-05 | 171 | 45 | 4 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 177 | 45 | 4 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-05 | 177 | 45 | 4 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.11e-05 | 178 | 45 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.11e-05 | 178 | 45 | 4 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 3.18e-05 | 179 | 45 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 180 | 45 | 4 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.25e-05 | 180 | 45 | 4 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-05 | 180 | 45 | 4 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.32e-05 | 181 | 45 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 181 | 45 | 4 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 181 | 45 | 4 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 181 | 45 | 4 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 181 | 45 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 182 | 45 | 4 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 184 | 45 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 184 | 45 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 184 | 45 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.61e-05 | 185 | 45 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 186 | 45 | 4 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 186 | 45 | 4 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 186 | 45 | 4 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 186 | 45 | 4 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.77e-05 | 187 | 45 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 1.59e-06 | 188 | 44 | 6 | 5596_UP | |
| Drug | D-Val-Phe-Lys-chloromethyl ketone | 3.65e-06 | 2 | 44 | 2 | CID005491924 | |
| Drug | NSC-343257 | 4.85e-06 | 228 | 44 | 6 | CID000004242 | |
| Drug | A0395 | 1.33e-05 | 75 | 44 | 4 | CID009906466 | |
| Drug | AC1L1DD6 | 2.41e-05 | 179 | 44 | 5 | CID000002299 | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A | 3.45e-05 | 193 | 44 | 5 | 4503_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.54e-05 | 194 | 44 | 5 | 6696_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.54e-05 | 194 | 44 | 5 | 2844_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 3.71e-05 | 196 | 44 | 5 | 2862_UP | |
| Drug | Delcorine; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.71e-05 | 196 | 44 | 5 | 4275_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.71e-05 | 196 | 44 | 5 | 4407_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.81e-05 | 197 | 44 | 5 | 5605_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.90e-05 | 198 | 44 | 5 | 5515_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.99e-05 | 199 | 44 | 5 | 6700_UP | |
| Drug | CTMs | 5.45e-05 | 6 | 44 | 2 | CID000192530 | |
| Drug | FR 139317 | 7.62e-05 | 7 | 44 | 2 | ctd:C079574 | |
| Drug | Rgd Peptide | 9.51e-05 | 239 | 44 | 5 | CID000104802 | |
| Drug | cobalt-60 | 9.90e-05 | 390 | 44 | 6 | CID000061492 | |
| Disease | Scoliosis, unspecified | 4.99e-05 | 8 | 40 | 2 | C0036439 | |
| Disease | diabetic nephropathy | 5.08e-05 | 150 | 40 | 4 | EFO_0000401 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.16e-05 | 53 | 40 | 3 | C4707243 | |
| Disease | Marfan Syndrome, Type I | 6.41e-05 | 9 | 40 | 2 | C4721845 | |
| Disease | Semantic-Pragmatic Disorder | 9.78e-05 | 11 | 40 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 9.78e-05 | 11 | 40 | 2 | C0751257 | |
| Disease | Language Delay | 9.78e-05 | 11 | 40 | 2 | C0023012 | |
| Disease | Language Development Disorders | 9.78e-05 | 11 | 40 | 2 | C0023014 | |
| Disease | Marfan Syndrome | 9.78e-05 | 11 | 40 | 2 | C0024796 | |
| Disease | Speech Delay | 9.78e-05 | 11 | 40 | 2 | C0241210 | |
| Disease | myocardial infarction | 1.07e-04 | 350 | 40 | 5 | EFO_0000612 | |
| Disease | caffeine measurement | 1.86e-04 | 15 | 40 | 2 | EFO_0021177 | |
| Disease | autism spectrum disorder (is_implicated_in) | 2.12e-04 | 16 | 40 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.41e-04 | 17 | 40 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | chronic kidney disease | 2.86e-04 | 235 | 40 | 4 | EFO_0003884 | |
| Disease | Adenoid Cystic Carcinoma | 3.41e-04 | 100 | 40 | 3 | C0010606 | |
| Disease | Congenital diaphragmatic hernia | 3.70e-04 | 21 | 40 | 2 | C0235833 | |
| Disease | PR interval | 5.28e-04 | 495 | 40 | 5 | EFO_0004462 | |
| Disease | creatinine measurement, glomerular filtration rate | 5.39e-04 | 117 | 40 | 3 | EFO_0004518, EFO_0005208 | |
| Disease | Malignant neoplasm of breast | 5.41e-04 | 1074 | 40 | 7 | C0006142 | |
| Disease | Heart valve disease | 5.70e-04 | 26 | 40 | 2 | C0018824 | |
| Disease | Endogenous Hyperinsulinism | 5.70e-04 | 26 | 40 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 5.70e-04 | 26 | 40 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 5.70e-04 | 26 | 40 | 2 | C1257965 | |
| Disease | Hyperinsulinism | 6.62e-04 | 28 | 40 | 2 | C0020459 | |
| Disease | Hyperglycemia, Postprandial | 7.61e-04 | 30 | 40 | 2 | C1855520 | |
| Disease | Hyperglycemia | 7.61e-04 | 30 | 40 | 2 | C0020456 | |
| Disease | hyperuricemia | 9.21e-04 | 33 | 40 | 2 | EFO_0009104 | |
| Disease | factor VIII measurement, venous thromboembolism | 9.78e-04 | 34 | 40 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 9.78e-04 | 34 | 40 | 2 | DOID:5082 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGTCYPTETSYVCTC | 3101 | P13611 | |
| ADCCTSYISQSIPCS | 51 | Q16663 | |
| SSNTCEPCSAYVICT | 411 | Q6A162 | |
| TDCVDSYTCTCPAGF | 961 | P46531 | |
| SCCSPSCYSSSCYST | 676 | Q76N89 | |
| PGASLKCTVCSYTAD | 331 | Q8WW38 | |
| GICKDEPSSYTCTTC | 161 | Q9H165 | |
| CTGYKESCCPVSSNT | 166 | Q96RD9 | |
| GSPVYSSKCQDCVCT | 4936 | Q02817 | |
| TAFSCTPDGRSYCCE | 1311 | O96028 | |
| STPCDPNSGSCYCKR | 481 | P55268 | |
| CTDTLTSFYCSCRPG | 3126 | P98164 | |
| EYEDSAGECCSCPKT | 701 | P06213 | |
| CNYDGGDCCTSTVKT | 1576 | Q13219 | |
| TASSCPASLTCDCYA | 341 | O00311 | |
| PASLTCDCYATDKVC | 346 | O00311 | |
| GSCTDLENSYSCTCP | 341 | O00548 | |
| NCEKKIDYCSSSPCS | 401 | O00548 | |
| GAVTKSECCCASTEY | 676 | P35555 | |
| GECCPVCSATVSYSL | 151 | O94769 | |
| KPVYCVPVCSGDSSC | 121 | P60409 | |
| CSKSVCYVPVCSGAS | 151 | P60014 | |
| LSTQCDSYGRCSCKP | 406 | P11047 | |
| FKCTCDETGYSGATC | 576 | Q9UHC6 | |
| CKCPPGYSGTICETT | 96 | P82279 | |
| GTLTCELKSCPYCTR | 691 | O95180 | |
| TCRSVGTSYKCLCDP | 481 | Q8NFT8 | |
| NCDCTPDYTRKSCTI | 126 | Q0D2K5 | |
| CALSCEASKEYSPCV | 776 | Q6ZRI0 | |
| TDSEPYSCSKSCSRT | 1406 | Q8TEU7 | |
| EPYCSCSDCQSPLST | 161 | Q7Z6W1 | |
| CYSTPSGCLELTDSC | 1371 | Q6P3W6 | |
| CYSTPSSCLEQPDSC | 1521 | Q6P3W6 | |
| CYSTPSGCLELTDSC | 2591 | Q6P3W6 | |
| CYSTPSSCLEQPDSC | 2741 | Q6P3W6 | |
| CYSTPSGCLELTDSC | 856 | A0A087WUL8 | |
| CYSTPSSCLEQPDSC | 1006 | A0A087WUL8 | |
| CYSTPSGCLELTDSC | 2076 | A0A087WUL8 | |
| CYSTPSSCLEQPDSC | 2226 | A0A087WUL8 | |
| CYSTPSGCLELTDSC | 3296 | A0A087WUL8 | |
| CYSTPSSCLEQPDSC | 3446 | A0A087WUL8 | |
| CYSTPSGCLELTDSC | 756 | P0DPF2 | |
| CYSTPSSCLEQPDSC | 906 | P0DPF2 | |
| CYSTPSGCLELTDSC | 1976 | P0DPF2 | |
| CYSTPSSCLEQPDSC | 2126 | P0DPF2 | |
| CYSTPSSCLEQPDSC | 3346 | P0DPF2 | |
| CYSTPSSCLEQPDSC | 4491 | P0DPF2 | |
| PCNEKCRCSSSIYSS | 501 | Q86UG4 | |
| YCKIPSCDSSPVSTE | 346 | P00747 | |
| TCKGVSYCTGNSSEC | 541 | P78536 | |
| KTYTVGCEECTVFPC | 141 | P01033 | |
| PYECTECGKAYSCSS | 491 | Q15935 | |
| PYICCECGKSFSNSS | 226 | Q5VV52 | |
| YCTDPSSVEGTCEEC | 286 | P07911 | |
| ATCEYSNGTASCICK | 841 | Q8WWQ8 | |
| VVACTEGTTYVCSVC | 706 | Q9HC78 | |
| PYECTECGKTFSKST | 226 | Q08ER8 | |
| KCPECSYSCSSAAAL | 496 | Q9NTW7 | |
| CIDCTTNFSCTYGKP | 81 | Q9BRN9 | |
| VPTCKTCGKTFSCSY | 471 | Q9H5J0 |